Medtronic Plc’s neurostimulator for Parkinson’s gets USFDA approval
Irelandâs Medtronic Plcâs deep brain stimulation device for patients with Parkinsonâs disease has been approved by the US Food and Drug Administration, according.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Irelandâs Medtronic Plcâs deep brain stimulation device for patients with Parkinsonâs disease has been approved by the US Food and Drug Administration, according.
Saudi Arabia has reaffirmed a $500 million pledge to the WHOâs Global Polio Eradication Initiative to fight the disease plaguing vulnerable children, according.
HQ Team February 24, 2025: Chinese virologists at the Wuhan Institute of Virology have found another bat coronavirus that carries the risk of.
US-based private equity and advisory investment firm KKR & Co. Inc. will pay CVC Capital Partners $400 million to acquire a majority stake.
Mirum Pharmaceuticals Inc.âs oral cholesterol drug for treating a rare metabolic disease has been approved by the Food and Drug Administration.
HQ Team February 21, 2025: Artificial sweeteners, long used as low-calorie alternatives to sugar, are known to cause a number of health conditions,.
Cambridge researchers have developed a reactor that pulls carbon dioxide directly from the air and converts it into sustainable fuel, using sunlight as.
The international humanitarian aid system of the United Nations, set up after the Second World War, is facing the âgreatest test since creationâ.
HQ Team February 21, 2025: FibroGen Inc., a US-based pharmaceutical company, will sell its China subsidiary to AstraZeneca Plc. for $160 million, allowing.
HQ Team February 20, 2025: A joint study by the University College London (UCL) and University College London Hospitals (UCLH) has revealed that.